Researchers at Michigan State University reviewed health records from more than 73,000 people using GLP-1 drugs.
Compared to others, users had a small but noticeable increase in risk: 0.9% higher for osteoporosis, 0.8% for gout, and 0.1% for osteomalacia.
While this doesn't prove the medications are directly to blame, experts say it's smart for anyone on these drugs, especially if you're at risk, to keep an eye on bone health going forward.